OPC Stock Overview
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
OPC Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫24,700.00 |
| 52 Week High | ₫25,650.00 |
| 52 Week Low | ₫21,550.00 |
| Beta | 0.21 |
| 1 Month Change | 2.92% |
| 3 Month Change | 7.63% |
| 1 Year Change | 7.39% |
| 3 Year Change | -3.99% |
| 5 Year Change | 21.48% |
| Change since IPO | 134.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPC | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -0.8% | -1.3% | 1.0% |
| 1Y | 7.4% | 15.7% | 14.9% |
Return vs Industry: OPC underperformed the VN Pharmaceuticals industry which returned 15.7% over the past year.
Return vs Market: OPC underperformed the VN Market which returned 14.9% over the past year.
Price Volatility
| OPC volatility | |
|---|---|
| OPC Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in VN Market | 7.0% |
| 10% least volatile stocks in VN Market | 2.4% |
Stable Share Price: OPC has not had significant price volatility in the past 3 months.
Volatility Over Time: OPC's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 926 | Huong Thi Pham | www.opcpharma.com |
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally. Its primary products include cardiovascular, nerve, nutrition, vitamins and minerals, respiratory system, urinary, musculoskeletal system, external use, digestion, endocrine, pain relief-inflammation, and others. The company also produces and trades in pharmaceutical products, materials, machinery, medical equipment, chemicals, cosmetics, functional foods, anti-malarial products, and food products; and alcoholic beverages, spirits, carbonated drinks, mineral water, and other beverages.
OPC Pharmaceutical Joint Stock Company Fundamentals Summary
| OPC fundamental statistics | |
|---|---|
| Market cap | ₫1.58t |
| Earnings (TTM) | ₫104.69b |
| Revenue (TTM) | ₫1.00t |
15.1x
P/E Ratio1.6x
P/S RatioIs OPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPC income statement (TTM) | |
|---|---|
| Revenue | ₫1.00t |
| Cost of Revenue | ₫526.46b |
| Gross Profit | ₫478.43b |
| Other Expenses | ₫373.74b |
| Earnings | ₫104.69b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.63k |
| Gross Margin | 47.61% |
| Net Profit Margin | 10.42% |
| Debt/Equity Ratio | 0% |
How did OPC perform over the long term?
See historical performance and comparison